BIOA (Bioage Labs) Total Long-Term Liabilities : $6.94 Mil (As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Bioage Labs Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Bioage Labs's Total Long-Term Liabilities for the quarter that ended in Mar. 2025 was $6.94 Mil.

Bioage Labs Total Long-Term Liabilities Historical Data

The historical data trend for Bioage Labs's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioage Labs Total Long-Term Liabilities Chart

Bioage Labs Annual Data

Trend

Dec22

Dec23

Dec24

Total Long-Term Liabilities

135.13

141.15

7.33

Bioage Labs Quarterly Data
	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Long-Term Liabilities	Get a 7-Day Free Trial					349.97	348.55	4.55	7.33	6.94

Bioage Labs Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Bioage Labs Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Bioage Labs's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioage Labs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bioage Labs Inc (NAS:BIOA) » Definitions » Total Long-Term Liabilities

Comparable Companies

Traded in Other Exchanges

Y7G:Germany

Address

1445A South 50th Street, Richmond, CA, USA, 94804

Website

https://www.bioagelabs.com

Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.